Literature DB >> 3979406

Determination of total and divided clearance without blood sampling and not using a whole-body counter or gamma camera.

A Kyuldjiev, V Kyuldjiev, V Ivanov, P Petrov.   

Abstract

A method is suggested for the determination of total and divided clearance on the basis of one renal function-excretion. The method, which can also be used for hydronephrotic cases, does not involve blood sampling or the use of a whole-body counter or gamma camera. The method was applied to 73 patients, 14 of whom presented with hydronephrosis. Of the 73 patients, 12 were comparatively examined, and the divided clearance was simultaneously determined in three different ways: graphically, by the areas enclosed between the blood-clearance heart curve and the beginning of the secretion phase of the nephrograms; by catheterizing and measuring the excreted urine from each kidney in a well-crystal detector; by the suggested method without taking blood samples. There was good agreement between the results obtained by the last two methods.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3979406     DOI: 10.1007/bf00261753

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  4 in total

1.  [Estimation of 131I hippuran clearance during pregnancy (author's transl)].

Authors:  R Voigt; W Stoll; I Zenner; J Arndt
Journal:  Rofo       Date:  1979-11

2.  A three-compartment model for the transport and distribution of Hippuran.

Authors:  L H van Stekelenburg; A Kooman; J F Tertoolen
Journal:  Phys Med Biol       Date:  1976-01       Impact factor: 3.609

3.  A new approach to the measurement of divided renal plasma flow by I-131-hippuran and external counting in humans.

Authors:  C Bianchi; A Coli; P Giannotti; A Lenaers
Journal:  Strahlentherapie Sonderb       Date:  1967

4.  [Reliability and limitations of total and divided renal clearances as determined with a partially shielded whole-body counter (author's transl)].

Authors:  P Heidenreich; M Oberdorfer; G Hör
Journal:  Nuklearmedizin       Date:  1979-02       Impact factor: 1.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.